Fairvalue-Calculator Fairvalue-Calculator

Urovo Technology Co (300531) Fair Value & Analysis

Technology · CN · Market cap 5.0B CNY

Price¥16.01
Fair Value¥5.31
Upside-66.8%
Quality95/100
Evidence: High Range ¥3.98 – ¥6.64

Analysis

Urovo Technology Co (300531) currently trades at ¥16.01, while our model-based Fair Value estimate is ¥5.31 — implying the stock looks roughly 66.8% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Urovo Technology Co., Ltd., together with its subsidiaries, manufactures and sells automatic identification and data collection terminal products in China and internationally. The company offers payment terminals; mobile computers comprising handheld mobile and wearable computers; RFID devices, such as handheld and fixed RFID readers, RFID sleds, and RFID printers; healthcare devices; rugged tablets; barcode scanners; and mobile and desktop laptop printers, as well as UROVO enterprise enabler, a cross-platform and cross-terminal software and cloud service platform. It also provides computer hardware, electronic products, smart mobile and financial terminals, mobile payment equipment, and mobile phones; technical support; and pre-sale and after sales services. The company's products are used in the logistics, retail, finance, healthcare, manufacturing, government, and transportation industries. Urovo Technology Co., Ltd. was founded in 2002 and is headquartered in Shenzhen, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.